Cava Beats Q2 Expectations as Mediterranean Demand Drives Strong Growth
Cava Group beat Q2 estimates with 31.3% revenue growth to $365.4M and 9% same-restaurant sales.
Already have an account? Sign in.
Cava Group beat Q2 estimates with 31.3% revenue growth to $365.4M and 9% same-restaurant sales.
Definium’s one-dose anxiety drug cut symptoms for 12 weeks, with mostly mild side effects, offering hope for a new treatment.
Q2 revenue of $7.9M missed estimates, while 2026 guidance was cut to $60–75M from $125M due to weak antimony prices.
Velo3D deepens partnerships with Mears Machine and Aurelia Technologies while supporting SpaceX as a major metal 3D printing supplier for aerospace and space programs.